DK0552202T3 - Fremgangsmåder medieret af det protoonkogene proteinkompleks AP-1 - Google Patents
Fremgangsmåder medieret af det protoonkogene proteinkompleks AP-1Info
- Publication number
- DK0552202T3 DK0552202T3 DK91917435.9T DK91917435T DK0552202T3 DK 0552202 T3 DK0552202 T3 DK 0552202T3 DK 91917435 T DK91917435 T DK 91917435T DK 0552202 T3 DK0552202 T3 DK 0552202T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- date
- glucocorticoid
- genes
- repress
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58618790A | 1990-09-21 | 1990-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0552202T3 true DK0552202T3 (da) | 1996-06-03 |
Family
ID=24344674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91917435.9T DK0552202T3 (da) | 1990-09-21 | 1991-09-20 | Fremgangsmåder medieret af det protoonkogene proteinkompleks AP-1 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5639592A (fr) |
EP (1) | EP0552202B2 (fr) |
JP (1) | JPH06503642A (fr) |
AT (1) | ATE133267T1 (fr) |
AU (1) | AU655943B2 (fr) |
CA (1) | CA2090407A1 (fr) |
DE (1) | DE69116563T3 (fr) |
DK (1) | DK0552202T3 (fr) |
ES (1) | ES2082231T3 (fr) |
GR (1) | GR3018708T3 (fr) |
WO (1) | WO1992005447A1 (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69133402T2 (de) | 1990-04-04 | 2004-11-11 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Protease von hepatitis-c-virus |
US6683047B1 (en) | 1990-10-10 | 2004-01-27 | The Burnham Institute | Method of inhibiting transcription utilizing nuclear receptors |
WO1992007072A1 (fr) * | 1990-10-10 | 1992-04-30 | La Jolla Cancer Research Foundation | Procede d'inhibition de transcription utilisant des recepteurs nucleaires |
US6004748A (en) * | 1990-10-10 | 1999-12-21 | La Jolla Cancer Research Foundation | Method of inhibiting transcription utilizing nuclear receptors |
GB9208135D0 (en) | 1992-04-13 | 1992-05-27 | Ludwig Inst Cancer Res | Polypeptides having kinase activity,their preparation and use |
US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
US20050084885A1 (en) * | 1994-01-18 | 2005-04-21 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
GB9601042D0 (en) * | 1996-01-17 | 1996-03-20 | Smithkline Beecham Plc | Medical use |
GB9414157D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Medical use |
EP0781331B1 (fr) | 1994-08-20 | 2008-09-03 | Gendaq Limited | Ameliorations concernant des proteines de liaison permettant de reconnaitre l'adn |
GB9420735D0 (en) * | 1994-10-14 | 1994-11-30 | Karobio Ab | Reporter cell line |
US6489441B1 (en) * | 1995-09-01 | 2002-12-03 | The Salk Institute For Biological Studies | Transcriptional co-repressor that interacts with nuclear hormone receptors |
US6028052A (en) | 1995-09-18 | 2000-02-22 | Ligand Pharmaceuticals Incorporated | Treating NIDDM with RXR agonists |
GB9710809D0 (en) * | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
US6562589B1 (en) | 1997-06-17 | 2003-05-13 | The United States Of America As Represented By The Department Of Health And Human Services | AIB1, a novel steroid receptor co-activator |
CN1271365A (zh) * | 1997-08-01 | 2000-10-25 | 阿尔塔切姆法尔马有限公司 | 具有抗-ks和抗hiv活性的化合物 |
US6852496B1 (en) * | 1997-08-12 | 2005-02-08 | Oregon Health And Science University | Methods of screening for agents that promote nerve cell growth |
WO1999011760A1 (fr) * | 1997-09-04 | 1999-03-11 | The Regents Of The University Of California | ACTIVATION DIFFERENTIELLE DES LIGANDS DES RECEPTEURS ERα ET ERβ DE L'OESTROGENE DANS LES SITES AP1 |
US5968921A (en) | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
US6410248B1 (en) | 1998-01-30 | 2002-06-25 | Massachusetts Institute Of Technology | General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites |
AU746454B2 (en) * | 1998-03-02 | 2002-05-02 | Massachusetts Institute Of Technology | Poly zinc finger proteins with improved linkers |
US6977154B1 (en) | 1998-03-17 | 2005-12-20 | Gendaq Limited | Nucleic acid binding proteins |
DE69905877T2 (de) | 1998-06-02 | 2003-11-20 | Arthromics Plc Wilmslow | Substanzen, die mit dem thyroid-hormonrezeptor interagieren, zur behandlung fibrotischer erkrankungen |
US6140081A (en) * | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
US6599692B1 (en) * | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
US7013219B2 (en) * | 1999-01-12 | 2006-03-14 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6453242B1 (en) * | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
US7070934B2 (en) | 1999-01-12 | 2006-07-04 | Sangamo Biosciences, Inc. | Ligand-controlled regulation of endogenous gene expression |
US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
US7030215B2 (en) * | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US20030104526A1 (en) * | 1999-03-24 | 2003-06-05 | Qiang Liu | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US6734211B1 (en) | 1999-07-09 | 2004-05-11 | Oregon Health & Sciences University | Compositions and methods for promoting nerve regeneration |
AU776576B2 (en) | 1999-12-06 | 2004-09-16 | Sangamo Biosciences, Inc. | Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
DK1741447T3 (da) | 2000-01-21 | 2013-12-09 | Novartis Ag | Kombinationer omfattende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler |
AU2693501A (en) * | 2000-01-24 | 2001-07-31 | Gendaq Ltd | Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules |
US7067317B2 (en) * | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
WO2002046412A2 (fr) * | 2000-12-07 | 2002-06-13 | Sangamo Biosciences, Inc. | Regulation de l'angiogenese au moyen de proteines a doigts de zinc |
WO2002057294A2 (fr) * | 2001-01-22 | 2002-07-25 | Sangamo Biosciences, Inc. | Proteines a doigts de zinc pour la fixation de l'adn et la regulation genique dans les plantes |
US7067617B2 (en) * | 2001-02-21 | 2006-06-27 | The Scripps Research Institute | Zinc finger binding domains for nucleotide sequence ANN |
KR20030046896A (ko) * | 2001-12-07 | 2003-06-18 | 학교법인 포항공과대학교 | 당질코르티코이드에 의해 발현이 조절되는 재조합 리포터유전자를 가지는 형질전환 세포주 및 이를 이용한당질코르티코이드 유사물질 및 저해물질의 생물학적검색방법 |
US7262054B2 (en) * | 2002-01-22 | 2007-08-28 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
EP1388352A1 (fr) | 2002-08-08 | 2004-02-11 | Laboratoires Fournier S.A. | Utilisation d'un agoniste de PPAR-alpha pour traiter l'obesité associée au traitement avec un agonist de PPAR-gamma dans des patients |
US7361635B2 (en) * | 2002-08-29 | 2008-04-22 | Sangamo Biosciences, Inc. | Simultaneous modulation of multiple genes |
AU2006290908C1 (en) | 2005-09-14 | 2014-04-03 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetes |
WO2011041293A1 (fr) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Dérivés pyrazolo [1, 5a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose |
JP5711270B2 (ja) | 2010-02-03 | 2015-04-30 | 武田薬品工業株式会社 | アポトーシスシグナル調節キナーゼ1阻害剤 |
CN117120096A (zh) * | 2020-11-06 | 2023-11-24 | 小利兰·斯坦福大学托管委员会 | 经由转录因子-化学诱导临近(tf-cip)调节基因表达 |
-
1991
- 1991-09-20 ES ES91917435T patent/ES2082231T3/es not_active Expired - Lifetime
- 1991-09-20 AU AU86309/91A patent/AU655943B2/en not_active Ceased
- 1991-09-20 DK DK91917435.9T patent/DK0552202T3/da active
- 1991-09-20 US US08/030,330 patent/US5639592A/en not_active Expired - Fee Related
- 1991-09-20 WO PCT/US1991/006848 patent/WO1992005447A1/fr active IP Right Grant
- 1991-09-20 CA CA002090407A patent/CA2090407A1/fr not_active Abandoned
- 1991-09-20 AT AT91917435T patent/ATE133267T1/de not_active IP Right Cessation
- 1991-09-20 EP EP91917435A patent/EP0552202B2/fr not_active Expired - Lifetime
- 1991-09-20 JP JP3516072A patent/JPH06503642A/ja active Pending
- 1991-09-20 DE DE69116563T patent/DE69116563T3/de not_active Expired - Fee Related
-
1996
- 1996-01-18 GR GR950402161T patent/GR3018708T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3018708T3 (en) | 1996-04-30 |
US5639592A (en) | 1997-06-17 |
EP0552202B2 (fr) | 2005-09-28 |
WO1992005447A1 (fr) | 1992-04-02 |
DE69116563T3 (de) | 2006-07-06 |
DE69116563D1 (de) | 1996-02-29 |
AU8630991A (en) | 1992-04-15 |
CA2090407A1 (fr) | 1992-03-22 |
DE69116563T2 (de) | 1996-07-04 |
AU655943B2 (en) | 1995-01-19 |
EP0552202A1 (fr) | 1993-07-28 |
JPH06503642A (ja) | 1994-04-21 |
ES2082231T3 (es) | 1996-03-16 |
EP0552202B1 (fr) | 1996-01-17 |
ATE133267T1 (de) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0552202T3 (da) | Fremgangsmåder medieret af det protoonkogene proteinkompleks AP-1 | |
Powell et al. | HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing | |
DK0760857T3 (da) | Receptor for onkostatin M | |
ATE220421T1 (de) | Identifizierung und expression von insekten- steroidrezeptor-dns-sequenzen | |
NO962991L (no) | Zink-finger-proteinderivater og fremgangsmåter derav | |
FI943260A0 (fi) | Vedenkestävä, irrotettava, paineherkkä tarra akryyliemulsiosta | |
EP0550592A4 (en) | Screening assays | |
Salkowski et al. | IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages. | |
DE69412286T2 (de) | Verwendung von blattförmigen materialien für festphasenextraktionen und festphasenreaktionen | |
DE69029812T2 (de) | Elemente für retinsäureantwortzusammensetzung und nachweisverfahren | |
DE69129990D1 (de) | Modifizierter menschlicher tumornekrosisfaktor-alpha-rezeptor | |
DE59608154D1 (de) | Verwendung von polyasparaginsäureamiden als lederhilfsmittel | |
DK0639275T3 (da) | Hidtil ukendte GABAa-receptorundertyper og fremgangsmåder til screening af lægemiddelforbindelser under anvendelse af imidazoquinoxaliner og pyrrolopyimidiner til binding til GABAa-receptorundertyper | |
ATE217649T1 (de) | Synthetische eukaryotische promotoren welche zwei induzierbare elemente enthalten | |
FR2706618B1 (fr) | Dispositif pour le dosage d'haptènes et son utilisation. | |
DE69636013D1 (de) | Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze | |
DE122007000051I2 (de) | Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum | |
Czyz et al. | Selective Sp1 and Sp3 binding is crucial for activity of the integrin αV promoter in cultured endothelial cells | |
DE69432422D1 (de) | Methoden zum aufspüren von anti-östrogenverbindungen | |
DE69628527D1 (de) | Verwendung von metallbeschichtbare Strukturklebstoffe zum Kleben von Kompositen aus Cyanatestern. | |
Sridhar et al. | Platelet-derived growth factor-stimulated expression of the MCP-1 immediate-early gene involves an inhibitory multiprotein complex | |
Karin | Transcriptional control and the integration of cell-autonomous and environmental cues during development | |
DE68905505T2 (de) | Personenkontrollsystem unter verwendung von ic-karten. | |
ATE362540T1 (de) | Kontrolle der pflanzlichen abszission und schotendehiszenz oder schotenabwurfs | |
DE69020520T2 (de) | 2,19-Methylenoxy- und 2,19-methylenthiogebrückte Steroide und ihre Verwendung als Inhibitoren von Aromatase und 19-Hydroxylase. |